<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04938479</url>
  </required_header>
  <id_info>
    <org_study_id>PI2020_843_0159</org_study_id>
    <nct_id>NCT04938479</nct_id>
  </id_info>
  <brief_title>D-dimer Prognostic Marker of Cerebral Infarction After Revascularization Procedure</brief_title>
  <acronym>D-Dimer</acronym>
  <official_title>D-dimer Prognostic Marker of Cerebral Infarction After Revascularization Procedure</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Centre Hospitalier Universitaire, Amiens</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Centre Hospitalier Universitaire, Amiens</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Cerebral infarction is the leading cause of acquired disability in adults. Absence of&#xD;
      biological marker used in current practice and identified as a prognostic factor for&#xD;
      recovery. D-dimers are degradation products of stabilized fibrin translating an activation of&#xD;
      coagulation whatever the cause. Studies have shown that increased D-dimer levels in patients&#xD;
      with MI is associated with a higher mortality rate, the link with post-intervention&#xD;
      non-revascularization has been demonstrate.&#xD;
&#xD;
      The purpose of this project is to search for a correlation between the level of D-dimer and&#xD;
      the degree of recovery evaluated by the NIHSS score&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">June 15, 2021</start_date>
  <completion_date type="Anticipated">April 2022</completion_date>
  <primary_completion_date type="Anticipated">April 2022</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Only</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Correlation between D-dimer concentration and NIHSS score</measure>
    <time_frame>3 months</time_frame>
    <description>NIHSS score is based on the clinical neurological examination of the patient. Validated by the scientific community of vascular neurology, among other things in projective clinical research. This score has high inter-observer reproducibility Expressed quantitatively on a scale of 0 to 42 for the NIHSS score A high value of the NIHSS score indicates poor recovery.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Correlation between D-dimer concentration and NIHSS score</measure>
    <time_frame>6 months</time_frame>
    <description>NIHSS score is based on the clinical neurological examination of the patient. Validated by the scientific community of vascular neurology, among other things in projective clinical research. This score has high inter-observer reproducibility Expressed quantitatively on a scale of 0 to 42 for the NIHSS score A high value of the NIHSS score indicates poor recovery.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Correlation between D-dimer concentration and the Rankin score</measure>
    <time_frame>3 months</time_frame>
    <description>Rankin Scale collected by the neurologist in consultation 3-6 months post stroke.&#xD;
Expressed quantitatively on a scale of 0 to 6 for the Rankin scale. A high value of the Rankin scale indicates poor recovery.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Correlation between D-dimer concentration and the Rankin score</measure>
    <time_frame>6 months</time_frame>
    <description>Rankin Scale collected by the neurologist in consultation 3-6 months post stroke.&#xD;
Expressed quantitatively on a scale of 0 to 6 for the Rankin scale. A high value of the Rankin scale indicates poor recovery.</description>
  </primary_outcome>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Cerebral Infarction</condition>
  <condition>Cerebral Infarction Recovery</condition>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>blood sample</intervention_name>
    <description>D-dimer measurement in blood sample</description>
  </intervention>
  <biospec_retention>Samples Without DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      D-Dimer measurement in blood sample&#xD;
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        patients under 65 years of age who have presented a heart attack brain and undergoing a&#xD;
        revascularization procedure&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patients aged 18 to 65&#xD;
&#xD;
          -  Cerebral infarctions undergoing a revascularization procedure by thrombolysis and / or&#xD;
             thrombectomy, at the Amiens University Hospital between January 2015 and December&#xD;
             2020.&#xD;
&#xD;
          -  Patients having benefited from a D-dimer assay (during their stay)&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
        -&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Audrey ARNOUX-COURSELLE, MD</last_name>
    <phone>0322668000</phone>
    <email>arnoux.audrey@chu-amiens.fr</email>
  </overall_contact>
  <location>
    <facility>
      <name>CHU Amiens</name>
      <address>
        <city>Amiens</city>
        <zip>80480</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Audrey ARNOUX-COURSELLE, MD</last_name>
      <phone>0322668000</phone>
      <email>arnoux.audrey@chu-amiens.fr</email>
    </contact>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>June 2021</verification_date>
  <study_first_submitted>June 17, 2021</study_first_submitted>
  <study_first_submitted_qc>June 17, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">June 24, 2021</study_first_posted>
  <last_update_submitted>June 25, 2021</last_update_submitted>
  <last_update_submitted_qc>June 25, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">June 28, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Cerebral Infarction</keyword>
  <keyword>cerebral infarction recovery</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Cerebral Infarction</mesh_term>
    <mesh_term>Infarction</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

